aluminum oxide has been researched along with dinoprostone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Launay, SM; Meunier, A; Sedel, L; Simeon, J; Villette, JM | 1 |
| Osborn, JF; Wittenberg, JM; Wittenberg, RH | 1 |
| Boyan, BD; Buchhorn, GH; Casasola, D; Dean, DD; Fink, U; Köster, G; Lohmann, CH; Schwartz, Z | 1 |
| Beneytout, JL; Bernache-Assollant, D; Charissoux, JL; Liagre, B; Moalic, S; Vergne, P | 1 |
| De Santis, V; Falcone, G; Galli, M; Navarra, P; Pozzetto, U; Pozzoli, G; Toriani Terenzi, C; Tringali, G; Vairano, M | 1 |
| Anger, DB; Jancar, S; Martins, DO; Martins, JO; Sannomiya, P; Wittlin, BM | 1 |
| Coleman, DC; Fleming, GJ; McGinley, EL; Moran, GP | 1 |
7 other study(ies) available for aluminum oxide and dinoprostone
| Article | Year |
|---|---|
Prostaglandin E2 level in tissue surrounding aseptic failed total hips. Effects of materials.
Topics: Acetabulum; Aluminum Oxide; Cementation; Dinoprostone; Hip Prosthesis; Humans; Metals; Polyethylenes; Prosthesis Failure; Reoperation | 1992 |
Prostaglandin release from rat femurs after implantation of hydroxylapatite and aluminium oxide ceramics.
Topics: Aluminum Oxide; Animals; Bone and Bones; Ceramics; Dinoprost; Dinoprostone; Durapatite; Femur; Male; Osteitis; Prostaglandins; Prostheses and Implants; Rats; Rats, Sprague-Dawley | 1995 |
Ceramic and PMMA particles differentially affect osteoblast phenotype.
Topics: Alkaline Phosphatase; Aluminum Oxide; Biocompatible Materials; Bone Cements; Cell Division; Ceramics; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Humans; Microscopy, Electron; Osteoblasts; Phagocytosis; Phenotype; Polymethyl Methacrylate; Prostheses and Implants; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Zinc Oxide | 2002 |
Effects of alumina and zirconium dioxide particles on arachidonic acid metabolism and proinflammatory interleukin production in osteoarthritis and rheumatoid synovial cells.
Topics: Aluminum Oxide; Arachidonic Acid; Arthritis, Rheumatoid; Biocompatible Materials; Biomedical and Dental Materials; Cell Culture Techniques; Connective Tissue Cells; Dinoprostone; Eicosanoids; Humans; Inflammation; Interleukin-1; Interleukin-6; Materials Testing; Models, Biological; Osteoarthritis; Zirconium | 2002 |
Metallic but not ceramic wear particles increase prostaglandin E2 release and interleukin-1beta gene expression in human blood monocytes in vitro.
Topics: Aluminum Oxide; Cell Survival; Cells, Cultured; Ceramics; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Interleukin-1; Lipopolysaccharides; Lymphocytes; Metals; Monocytes; RNA, Messenger | 2006 |
Early phase of allergic airway inflammation in diabetic rats: role of insulin on the signaling pathways and mediators.
Topics: Aluminum Oxide; Animals; Bronchoalveolar Lavage Fluid; Chemokines, CXC; Diabetes Mellitus, Experimental; Dinoprostone; Extracellular Signal-Regulated MAP Kinases; Insulin; Interleukin-6; Male; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Ovalbumin; Phosphatidylinositol 3-Kinases; Phosphorylation; Pneumonia; Protein Kinase C-alpha; Protein Kinase C-delta; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction | 2010 |
Effects of surface finishing conditions on the biocompatibility of a nickel-chromium dental casting alloy.
Topics: Air Abrasion, Dental; Aluminum Oxide; Analysis of Variance; Cell Line, Transformed; Cell Proliferation; Cell Survival; Chromium Alloys; Corrosion; Dental Casting Technique; Dental Polishing; Dinoprostone; Humans; Inflammation Mediators; Interleukins; Keratinocytes; L-Lactate Dehydrogenase; Mass Spectrometry; Materials Testing; Metals; Mouth Mucosa; Nickel; Spectrophotometry, Atomic; Surface Properties; Tumor Necrosis Factor-alpha | 2011 |